Comparing the Population-Based Frequency of Contraindicated Drug-Drug Interactions Between Daclatasvir/Sofosbuvir (DAC/SOF), Grazoprevir/Elbasvir (GZR/EBV), Ledipasvir/Sofosbuvir (LDV/SOF), Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin (OMB/PTV/RTV + DSV ± RBV) and Simeprevir/Sofosbuvir (SIM/SOF) for Treatment of Hepatitis C Monoinfection

Autor:	Kelly Rose Delehanty, Jenna Yager, Alisha Ahmed, Nimish Patel, Ronish Amin, Christopher A. Schriever
Rok vydání:	2016
Předmět:	Simeprevir Ledipasvir Elbasvir Daclatasvir Dasabuvir Sofosbuvir business.industry Virology Ombitasvir chemistry.chemical_compound Infectious Diseases Oncology Grazoprevir chemistry medicine business medicine.drug
Zdroj:	Open Forum Infectious Diseases. 3
ISSN:	2328-8957
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::65e5116aeb6503263e046aacc4ae216d https://doi.org/10.1093/ofid/ofw172.333 Zobrazit plný text záznamu